AM 281: CB1 Cannabinoid Receptor Antagonist for Neurotrauma
2026-07-15
AM 281 is a selective CB1 cannabinoid receptor antagonist transforming neurotrauma and cognitive dysfunction research. Its precision and performance, as validated in TBI and memory impairment models, make it indispensable for dissecting CB1 signaling in translational neuropharmacology.
Allosteric PDK4 Inhibitors Enable Precision Metabolic Modula
2026-07-15
The referenced study introduces a series of highly selective allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), with compound 8c showing nanomolar potency and favorable pharmacokinetics. These findings advance the potential for precise modulation of mitochondrial metabolism in models of diabetes, allergic disease, and cancer.
Lipid Scrambling Regulates Ferroptosis and Tumor Immune Reje
2026-07-14
Yang et al. identify TMEM16F-mediated lipid scrambling as a key suppressor of ferroptosis during its execution phase, showing that loss of TMEM16F heightens tumor cell death and enables immune rejection. This discovery delineates a novel membrane-centric mechanism by which phospholipid dynamics modulate cell fate and informs future therapeutic strategies targeting redox and membrane remodeling.
Biotin-tyramide: Technical Guidance for TSA Amplification Wo
2026-07-14
Biotin-tyramide is a high-purity biotinylation reagent optimized for tyramide signal amplification (TSA) in immunohistochemistry (IHC) and in situ hybridization (ISH) protocols using horseradish peroxidase (HRP). It enables precise, high-resolution detection at low-abundance target sites. This product is not suitable for direct use in aqueous solutions or diagnostic applications.
Dual-Action Inhibition Drives p38α MAPK Dephosphorylation Dy
2026-07-13
The referenced study demonstrates that certain kinase inhibitors not only block p38α MAP kinase activity but also promote its dephosphorylation by stabilizing a conformation accessible to phosphatases. This dual-action mechanism offers new strategies for designing more specific and potent inhibitors in inflammatory disease research.
PERK–JAK1–STAT3 Pathway Drives Pyroptosis in Disc Cells unde
2026-07-13
This study elucidates how endoplasmic reticulum stress (ERS) in nucleus pulposus cells triggers inflammatory pyroptosis through PERK-dependent activation of the JAK1–STAT3 pathway, accelerating intervertebral disc degeneration. By mapping this molecular cascade, the research highlights new therapeutic targets to mitigate disc cell loss and inflammation in degenerative disc disease.
Senescence and Cytoskeletal Changes in UCMSCs from Preeclamp
2026-07-12
This study identifies cellular senescence and cytoskeletal instability as key abnormalities in umbilical cord mesenchymal stem cells (UCMSCs) derived from preeclampsia patients. The findings highlight potential therapeutic targets and underscore the importance of precise S-phase DNA synthesis measurement in cellular research.
CYP51 Mutations and DMI Resistance in Cercospora beticola
2026-07-10
This study investigates how synonymous and nonsynonymous mutations in the CbCyp51 gene influence demethylation inhibitor (DMI) fungicide resistance in Cercospora beticola, a major sugar beet pathogen. By generating mutant strains and analyzing gene expression and resistance phenotypes, the research highlights the complex genetic mechanisms underpinning DMI resistance, informing future strategies for disease management.
PP 2 (AG 1879): Precision Src Kinase Inhibition in Cancer Re
2026-07-09
PP 2 (AG 1879) stands out as a nanomolar-potency Src family kinase inhibitor, enabling rigorous dissection of oncogenic and immunological signaling. Recent work on cytoskeletal regulation highlights its value for mapping complex pathways in cell morphogenesis and invasion assays.
Quaternization Enables Lung-Selective mRNA Delivery via Lipi
2026-07-09
The reference study demonstrates that quaternizing lipid-like nanoassemblies converts their organ tropism from the spleen to the lung, enabling highly selective mRNA delivery after intravenous administration. This innovation provides a simple, ligand-free platform for lung-targeted mRNA therapeutics and expands the scope of non-liver gene delivery.
AZD-3463: Deep Mechanistic Insights and Translational Levera
2026-07-08
Explore how the ALK/IGF1R inhibitor AZD3463 enables advanced interrogation of PI3K/AKT/mTOR signaling and apoptosis induction in ALK-driven cancer research. This article delivers novel mechanistic perspectives and practical assay guidance beyond current literature.
SMYD2 Inhibition Attenuates Cisplatin-Induced Renal Fibrosis
2026-07-08
This study reveals that pharmacological inhibition of SMYD2, particularly through AZ505, significantly mitigates cisplatin-induced renal fibrosis and inflammation in murine models. The research highlights SMYD2 as a key epigenetic regulator in chronic kidney disease (CKD), opening new avenues for targeted intervention in renal pathology.
MK-0812: Transforming CCR2-Driven Inflammation Research
2026-07-07
Explore MK-0812, a potent CCR2 antagonist, as an advanced tool for dissecting monocyte trafficking and MCP-1 signaling in immunometabolic disease models. This article delves into mechanistic depth, protocol optimization, and new insights from gut–liver axis research, offering unique guidance for researchers using MK-0812.
Triterpene Prodrug Self-Assembly for Targeted OSCC Therapy
2026-07-07
This study introduces a carrier-free, self-assembled triterpene-based prodrug platform for targeted oral squamous cell carcinoma (OSCC) chemotherapy. By leveraging natural product self-assembly and ROS-responsive release, the approach enhances tumor specificity and drug efficacy while minimizing systemic toxicity.
Latrunculin A: Reversible Inhibitor of Actin Assembly in Res
2026-07-06
Latrunculin A empowers researchers to dissect actin–myosin II network function, enabling precise and reversible actin cytoskeleton disruption for advanced studies of cell morphology, motility, and host–pathogen interactions. This article translates recent proteomic breakthroughs into actionable workflows and troubleshooting strategies, positioning Latrunculin A from APExBIO as an essential tool for modern cell biology.
461 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page